Drugs / lidocaine/prilocaine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02976727 Background | May 2014 → Aug 2015 | actinic keratosis | Dong-A University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lidocaine/prilocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02976727 ↗ |
| Known as | EMLA | “For AFL pre-treatment, lidocaine/prilocaine (5%) cream (EMLA; Astra Pharmaceuticals, LP, Westborough, MA, USA) was applied to the treatment area under occlusion for 30 min” NCT02976727 ↗ |
| Route | Topical | “was applied to the treatment area under occlusion” NCT02976727 ↗ |